CEO Equity Ownership at European Biopharma Companies

Published: July 2019

 

CEOs are more likely to have a significant ownership percentage of the overall company equity – they have a large amount of accountability and are tasked with strategically steering their organisations toward success. Using our proprietary data, we’ve highlighted a few key findings in CEO ownership at European biopharma companies, and we’re prepared to dive deeper into your questions to help shape and inform your rewards strategy.

General Disclaimer
The information contained herein and the statements expressed are of a general nature and are not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information and use sources we consider reliable, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation.

Terms of Use
The contents herein may not be reproduced, reused, reprinted or redistributed without the expressed written consent of Aon, unless otherwise authorized by Aon. To use information contained herein, please write to our team.



Talk to an Expert

Let us know how we can help and a member of our team will be in touch shortly.

Aon group companies will use your personal information to contact you from time to time about other products, services and events that we feel may be of interest to you. All personal information is collected and used in accordance with our privacy statement.

If you do not wish to receive these communications, please check here: